AlloHeme

AI-NGS Test Detects AML, MDS Relapse Post-Transplant

BRISBANE, Calif., Feb. 12, 2026 — CareDx announced pivotal clinical validation results for AlloHeme, the first AI-powered, next-generation sequencing...

By cGxPwire Editor
February 12, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

AlloHeme

AI-NGS Test Detects AML, MDS Relapse Post-Transplant